EntryPoint Capital’s Verve Therapeutics VERV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-37,174
Closed -$180K 980
2024
Q3
$180K Buy
+37,174
New +$180K 0.1% 493
2024
Q2
Sell
-92
Closed -$1.22K 1653
2024
Q1
$1.22K Sell
92
-1,739
-95% -$23.1K ﹤0.01% 1355
2023
Q4
$25.5K Buy
+1,831
New +$25.5K 0.02% 977